Cheryl Wright
Family · Portland, ORNPI 1558587766
Payments from drug & device makers
Across 98 payments — averaging $24.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$586
- AstraZeneca$246
- Kaleo, Inc.$216
- Collegium Pharmaceutical, Inc.$170
- Biotronik NRO, Inc.$150
- Regeneron Healthcare Solutions, Inc.$108
- plus $948 from 22 others
What the payments were for
- Food & beverage$2,35097%
- Education$733%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 24 | $586 |
| AstraZeneca | 11 | $246 |
| Kaleo, Inc. | 8 | $216 |
| Collegium Pharmaceutical, Inc. | 11 | $170 |
| Biotronik NRO, Inc. | 1 | $150 |
| Regeneron Healthcare Solutions, Inc. | 3 | $108 |
| Pfizer | 6 | $100 |
| Ipsen Biopharmaceuticals, Inc | 3 | $86 |
| Bioventus LLC | 2 | $71 |
| Abbott | 3 | $66 |
| Medtronic | 2 | $55 |
| Vertex | 2 | $52 |
| Novartis | 3 | $52 |
| MML US, Inc. | 1 | $52 |
| Mylan Specialty L.p. | 2 | $48 |
| Nalu Medical, Inc. | 1 | $47 |
| Atricure, Inc. | 1 | $45 |
| GSK | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33 |
| Biocryst US Sales Co., LLC | 2 | $32 |
| Sanofi | 2 | $31 |
| Genentech USA, Inc. | 1 | $24 |
| Boston Scientific | 1 | $22 |
| Blueprint Medicines Corporation | 1 | $22 |
| Nevro Corp. | 1 | $21 |
| Averitas Pharma Inc. | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Alk-abello, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prospera$150
How this compares
$2,424 in reported general payments places this provider in the 90th percentile of 1,130 family providers in Oregon.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 69 | $46,769 |
| Buprenorphine | 139 | $40,408 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 859 | $22,381 |
| Xtampza ErOxycodone Myristate | 24 | $21,589 |
| Oxycodone Hcl | 849 | $14,411 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 435 | $12,415 |
| Morphine Sulfate ErMorphine Sulfate | 293 | $9,149 |
| Buprenorphine Hcl | 203 | $7,178 |
| Fentanyl | 69 | $5,703 |
| Gabapentin | 205 | $3,806 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 12 | $3,380 |
| Pregabalin | 124 | $2,433 |
| Cyclobenzaprine Hcl | 130 | $2,101 |
| Methadone Hcl | 133 | $1,852 |
| Naloxone Hcl | 24 | $1,759 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $170 | $21,58924 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,130 family providers in Oregon.
Other family in Portland
- Rachel PangilinanPortland$103K
- Lani DoserPortland$45K
- Leah GaedekePortland$26K
- Susan ToftePortland$21K
- Leah WessenbergPortland$19K
- Christine YedinakPortland$19K
- Laurel ZuberiPortland$11K
- Nora LerschPortland$9K
- Jessica JamesPortland$7K
- Nathalia Gaviria-CorreaPortland$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.